CCM
LLY icon

Cadence Capital Management’s Eli Lilly LLY Stock Holding History

Cadence Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$2.79M Sell
18,816
-4,574
-20% -$708K 0.67% 34
2020
Q2 		$3.84M Sell
23,390
-3,301
-12% -$507K 0.56% 14
2020
Q1 		$3.7M Sell
26,691
-6,104
-19% -$839K 0.63% 18
2019
Q4 		$4.31M Sell
32,795
-2,338
-7% -$271K 0.46% 38
2019
Q3 		$3.93M Sell
35,133
-2,021
-5% -$225K 0.56% 32
2019
Q2 		$4.12M Buy
37,154
+2,790
+8% +$329K 0.41% 41
2019
Q1 		$4.46M Sell
34,364
-10,224
-23% -$1.24M 0.4% 50
2018
Q4 		$5.16M Sell
44,588
-43,652
-49% -$4.88M 0.52% 41
2018
Q3 		$9.47M Sell
88,240
-4,349
-5% -$435K 0.51% 49
2018
Q2 		$7.9M Sell
92,589
-5,970
-6% -$490K 0.47% 56
2018
Q1 		$7.63M Buy
98,559
+4,959
+5% +$399K 0.5% 54
2017
Q4 		$7.91M Sell
93,600
-2,065
-2% -$176K 0.5% 58
2017
Q3 		$8.18M Sell
95,665
-755
-0.8% -$61.9K 0.51% 58
2017
Q2 		$7.93M Sell
96,420
-2,960
-3% -$241K 0.55% 48
2017
Q1 		$8.36M Sell
99,380
-13,713
-12% -$1.1M 0.58% 48
2016
Q4 		$8.32M Buy
113,093
+14,537
+15% +$1.08M 0.58% 44
2016
Q3 		$7.91M Sell
98,556
-26,966
-21% -$2.16M 0.58% 47
2016
Q2 		$9.88M Sell
125,522
-3,521
-3% -$265K 0.75% 40
2016
Q1 		$9.29M Buy
129,043
+10,826
+9% +$819K 0.65% 47
2015
Q4 		$9.96M Buy
118,217
+11,616
+11% +$964K 0.67% 46
2015
Q3 		$8.92M Sell
106,601
-29,609
-22% -$2.5M 0.63% 50
2015
Q2 		$11.4M Buy
136,210
+17,448
+15% +$1.33M 0.63% 43
2015
Q1 		$8.63M Sell
118,762
-32,213
-21% -$2.29M 0.53% 51
2014
Q4 		$10.4M Buy
150,975
+4,353
+3% +$294K 0.61% 46
2014
Q3 		$9.51M Buy
146,622
+23,043
+19% +$1.46M 0.5% 58
2014
Q2 		$7.68M Sell
123,579
-84,971
-41% -$5.07M 0.37% 74
2014
Q1 		$12.3M Sell
208,550
-46,316
-18% -$2.58M 0.52% 21
2013
Q4 		$13M Buy
254,866
+7,533
+3% +$377K 0.49% 37
2013
Q3 		$12.4M Buy
+247,333
New +$12.9M 0.42% 44

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Cadence Capital Management's LLY Position: Q3 2020 in Review

Cadence Capital Management reduced its Eli Lilly (LLY) stake by 20% in Q3 2020, selling an estimated $708K and leaving 18,816 shares worth $2.79M. The position accounts for 0.67% of the portfolio, ranked #34.

Cadence Capital Management first reported a position in LLY in Q3 2013 and has held it in 29 quarters since. The position peaked at $13M in Q4 2013. 1,773 funds tracked by Wall St. Rank hold LLY as of Q3 2020.

  • Cadence Capital Management held 18,816 shares of Eli Lilly worth $2.79M as of Q3 2020.
  • Cadence Capital Management sold 4,574 Eli Lilly shares in Q3 2020, an estimated $708K.
  • Eli Lilly made up 0.67% of Cadence Capital Management's portfolio in Q3 2020, its #34 holding.
  • Cadence Capital Management first reported a position in Eli Lilly in Q3 2013 and has held it in 29 quarters since.
  • Cadence Capital Management's Eli Lilly position peaked at $13M in Q4 2013.
  • 1,773 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2020.

Based on Cadence Capital Management's 13F filing for Q3 2020, filed 16 Oct 2020.